(NOLA-B) Nolato (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015962477
NOLA-B EPS (Earnings per Share)
NOLA-B Revenue
NOLA-B: Medical Devices, Laboratory Products, Packaging Solutions, Industrial Components
Nolato AB (publ) is a global manufacturing company specializing in precision polymers, serving various high-tech industries, including medical technology, pharmaceuticals, consumer electronics, telecom, automotive, and hygiene. With a presence in Sweden, Hungary, Asia, Europe, and North America, the company leverages its expertise in plastic, silicone, and thermoplastic elastomer products to deliver customized solutions.
The companys product portfolio is diverse, encompassing catheter balloons, breathing bags, non-conductive sealing and damping silicone products, primary plastic packaging for medicines, and various laboratory products. Nolato also offers advanced manufacturing technologies, including injection molding, extrusion, and cleanroom production, as well as design and virtual prototyping solutions. Its products are designed to meet the stringent requirements of its clients, often serving as critical components in medical devices, pharmaceutical packaging, and electronic applications.
Given its strong market position and diversified product offerings, Nolato is well-positioned to capitalize on growth trends in its target markets. The medical technology and pharmaceutical sectors, in particular, are expected to drive demand for the companys high-precision products. With a proven track record of innovation and a commitment to quality, Nolato is poised for continued success.
Analyzing the
Examining the
Additional Sources for NOLA-B Stock
NOLA-B Stock Overview
Market Cap in USD | 1,601m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception |
NOLA-B Stock Ratings
Growth Rating | -11.4 |
Fundamental | 40.7 |
Dividend Rating | 9.10 |
Rel. Strength | 9.36 |
Analysts | - |
Fair Price Momentum | 51.75 SEK |
Fair Price DCF | 114.94 SEK |
NOLA-B Dividends
Dividend Yield 12m | 2.71% |
Yield on Cost 5y | 2.74% |
Annual Growth 5y | -36.03% |
Payout Consistency | 81.7% |
Payout Ratio | 57.9% |
NOLA-B Growth Ratios
Growth Correlation 3m | 38.5% |
Growth Correlation 12m | 25.3% |
Growth Correlation 5y | -57.1% |
CAGR 5y | 0.52% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -1.59 |
Alpha | -10.87 |
Beta | 0.645 |
Volatility | 34.72% |
Current Volume | 528.6k |
Average Volume 20d | 120.5k |
As of June 24, 2025, the stock is trading at SEK 56.25 with a total of 528,646 shares traded.
Over the past week, the price has changed by -2.60%, over one month by +0.45%, over three months by -3.13% and over the past year by -0.55%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Nolato (publ) (ST:NOLA-B) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.67 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NOLA-B is around 51.75 SEK . This means that NOLA-B is currently overvalued and has a potential downside of -8%.
Nolato (publ) has no consensus analysts rating.
According to our own proprietary Forecast Model, NOLA-B Nolato (publ) will be worth about 57.1 in June 2026. The stock is currently trading at 56.25. This means that the stock has a potential upside of +1.44%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 64.3 | 14.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 57.1 | 1.4% |